Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma

NCT04543071 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer
Adenocarcinoma of the Pancreas
Adenocarcinoma

Interventions

DRUG: Motixafortide
DRUG: Cemiplimab
DRUG: Gemcitabine
DRUG: Nab paclitaxel

Sponsor

Gulam Manji

Collaborators

[object Object]
[object Object]